|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of interleukin 27 DNA.|
|p28, Il30, IL-27, IL-27p28|
|Identical with the Gene Bank Ref. ID sequence.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Mouse IL27 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||MG51107-G-F|
|Mouse IL27 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||MG51107-G-H|
|Mouse IL27 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||MG51107-G-M|
|Mouse IL27 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||MG51107-G-N|
|Mouse IL27 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||MG51107-G-Y|
|Product name||Product name|
IL-27 protein is a member of the IL-6 superfamily, which is expressed on monocytes, endothelial cells and dendritic cells. IL-27 protein is also referred as the IL-12 p35-related protein, p28, is one subunit of a heterodimeric cytokine complex, and associates with another subunit EBI3 (EBV-induced gene 3), an IL-12 p40-related protein (IL-27B). IL-27 protein is an early product of activated antigen-presenting cells and drives rapid clonal expansion of naive CD4(+) T cells and plays a role in the early regulation of Th1 cells initiation which drives efficient adaptive immune response. IL-27 protein has an antiproliferative activity on melanomas through WSX-1/STAT1 signaling. Thus, IL-27 protein may be an attractive candidate as an antitumor agent applicable to cancer immunotherapy.